title: Genome-wide screening identifies new genes required for stress-induced phase 2 detoxification gene expression in animals.
abstract: BACKGROUND
  Phase 2 detoxification enzymes provide a vital defence against reactive oxygen species, including xenobiotic metabolites, which cause the oxidative damage involved in drug toxicity and many diseases. Hence, there is great interest in understanding how levels of these enzymes are regulated. CnC transcription factors, such as mammalian Nrf2, drive the expression of phase 2 enzymes and are activated as an important conserved response to oxidative stress and xenobiotics. For instance, the Caenorhabditis elegans Nrf2 orthologue, SKN-1, is activated in response to arsenite by the stress-activated p38-related kinase, PMK-1, leading to increased expression of phase 2 enzymes. Here we have used a genome-wide screening approach to identify other C. elegans genes that are required for stress-induced increases in phase 2 detoxification gene expression.
  
  
  RESULTS
  Taking advantage of the elevated phase 2 gene expression in a mutant lacking the peroxidase PRDX-2, we have identified many new genes that are required for stress-induced expression of gcs-1, a phase 2 enzyme critically required for glutathione synthesis. Significantly, these include genes previously implicated in resistance to ionizing radiation, longevity and responses to pathogenic infection. Many of these new candidate activators of gcs-1 are also required for the stress-induced intestinal expression of other phase 2 genes. However, intriguingly, our data suggest other factors may be specifically required for the stress-induced expression of gcs-1. Notably, we demonstrate that the candidate activator TIR-1(SARM1) and the MAPKKK NSY-1(Ask1) are required for the arsenite-induced activation of PMK-1. However, our data suggest that the majority of candidates participate in novel mechanisms to promote gcs-1 expression. For example, the E4 ubiquitin ligase UFD-2(UBE4B) is dispensable for PMK-1 activation but important for maintaining nuclear levels of SKN-1, the stress-induced expression of multiple SKN-1-target genes and oxidative stress resistance.
  
  
  CONCLUSIONS
  Here we present the first functional, genome-wide analysis identifying genes that are required for activation of phase 2 detoxification genes in an animal. Our study identifies potential new regulators of Nrf2, reveals that additional mechanisms promote the stress-induced expression of specific phase 2 detoxification genes and provides new insight into the relationships between these universally important stress defences, oxidative stress resistance and aging.
authors.forename: Helen M
authors.initials: HM
authors.lastname: Crook-McMahon
authors.forename: Monika
authors.initials: M
authors.lastname: Oláhová
authors.forename: Emma L
authors.initials: EL
authors.lastname: Button
authors.forename: Johnathan J
authors.initials: JJ
authors.lastname: Winter
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Veal
mesh_terms: D000818:Animals; D017173:Caenorhabditis elegans / Q000235:genetics* / Q000378:metabolism; D005786:Gene Expression Regulation / Q000235:genetics*; D049751:Genome, Helminth; D055106:Genome-Wide Association Study; D050217:Metabolic Detoxication, Phase II / Q000235:genetics*; D018384:Oxidative Stress; D017382:Reactive Oxygen Species / Q000378:metabolism; D013312:Stress, Physiological; D015262:Xenobiotics / Q000378:metabolism
chemical_list: D017382:Reactive Oxygen Species; D015262:Xenobiotics